Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

The Importance of the Number of Transplanted Cells with Dipeptidyl Peptidase-4 Expression on the Hematopoietic Recovery and Lymphocyte Reconstitution in Patients with Multiple Myeloma after Autologous Hematopoietic Stem-Cell Transplantation

Anna Kopinska, Malgorzata Krawczyk-Kulis, Joanna Dziaczkowska-Suszek, Katarzyna Bieszczad, Krystyna Jagoda, Slawomira Kyrcz-Krzemien, Prof

Blood (2015) 126 (23): 5415.

https://doi.org/10.1182/blood.V126.23.5415.5415

Published: 2015

Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Blood (2014) 124 (21): 3628.

https://doi.org/10.1182/blood.V124.21.3628.3628

Published: 2014

Journal Articles

CD26+ (dipeptidyl peptidase IV positive) Cells In Harvest Material For Multiple Myeloma Autotransplantation

Anna Kopinska, Malgorzata Krawczyk-Kulis, Joanna Suszek-Dziaczkowska, Katarzyna Bieszczad, Krystyna Jagoda, Slawomira Kyrcz-Krzemien, MD

Blood (2013) 122 (21): 5445.

https://doi.org/10.1182/blood.V122.21.5445.5445

Published: 2013

Journal Articles

Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma – a Retrospective Analysis

Iwona Hus, Dariusz Jawniak, Magdalena Gorska-Kosicka, Aleksandra Butrym, Justyna Dzietczenia, Tomasz Wrobel, Grzegorz Mazur, MD, PhD, Ewa Lech-Maranda, Krzysztof Warzocha, MD, PhD, Anna Waszczuk-Gajda, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, MD PhD Prof, Lidia Poplawska, Jan Walewski, Anna Dmoszynska

Blood (2012) 120 (21): 4602.

https://doi.org/10.1182/blood.V120.21.4602.4602

Published: 2012

Journal Articles

Efficacy and Safety of Conditioning Treatment Using Bendamustine in Autologous Hematopoietic Cell Transplantation in Heavily Pretreated Patient with Lymphoma

Malgorzata Krawczyk-Kulis, Anna Kopinska, Iwona Grygoruk-Wisniowska, Slawomira Kyrcz-Krzemien, MD PhD Prof

Blood (2012) 120 (21): 4537.

https://doi.org/10.1182/blood.V120.21.4537.4537

Published: 2012

Journal Articles

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

Malgorzata Krawczyk-Kulis, Anna Kopinska, Marek Seweryn, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD, PhD,

Blood (2011) 118 (21): 4519.

https://doi.org/10.1182/blood.V118.21.4519.4519

Published: 2011

Journal Articles

ATG Use Is Associated with Frequent Occurrence of Positive Blood Cultures in Patients in the Early Phase After Hematopoietic Stem Cell Transplantation

Marek Seweryn, Urszula Jarosz, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Grzegorz Helbig, Grazyna Bober, Slawomira Kyrcz-Krzemien

Blood (2011) 118 (21): 4564.

https://doi.org/10.1182/blood.V118.21.4564.4564

Published: 2011

Journal Articles

The Outcome of Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukaemia: A Single Centre 10-Year-Experience

Patrycja Zielinska, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Monika Dzierzak-Mietla, Anna Koclega, Robert Liwoch, Anna Kopinska, Slawomira Kyrcz-Krzemien

Blood (2011) 118 (21): 4515.

https://doi.org/10.1182/blood.V118.21.4515.4515

Published: 2011

Journal Articles

The Outcome of Autologous Stem Cell Transplantation and the Risk of Relapse in Myeloma and Lymphoma Patients Mobilized Using Plerixafor Compared to Standard Mobilization Regimen

Patrycja Zielinska, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Anna Koclega, Robert Liwoch, Monika Dzierzak-Mietla, Krzysztof Bialas, Slawomira Kyrcz-Krzemien

Blood (2011) 118 (21): 4399.

https://doi.org/10.1182/blood.V118.21.4399.4399

Published: 2011

Journal Articles

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

Blood (2010) 116 (21): 2138.

https://doi.org/10.1182/blood.V116.21.2138.2138

Published: 2010

Journal Articles

High-Dose Immunosuppressive Therapy (Cyclophosphamide and Campath-1H) Followed by Autologous Hematopoietic Stem Cell Transplantation In the Treatment of Systemic Sclerosis.

Tomasz Czerw, Malgorzata Widuchowska, Malgorzata Krawczyk-Kulis, Dariusz Kata, Magdalena Kopec-Medrek, Eugeniusz Jozef Kucharz, Slawomira Kyrcz-Krzemien, Prof, MD, PhD

Blood (2010) 116 (21): 4594.

https://doi.org/10.1182/blood.V116.21.4594.4594

Published: 2010

Journal Articles

Cladribine in Combination with Standard Daunorubicine and Cytarabine (DAC) as a Remission Induction Treatment Improves the Overall Survival in Untreated Adults with AML Aged < 60 y Contrary to Combination Including Fludarabine (DAF): A Multicenter, Randomized, Phase III PALG AML 1/2004 DAC/DAF/DA Study in 673 Patients-A Final Update.

Blood (2009) 114 (22): 2055.

https://doi.org/10.1182/blood.V114.22.2055.2055

Published: 2009

Journal Articles

Sequential Acquisition of Inhibitory NK Cell Receptors After Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Steroids and Other Transplantation-Related Factors.

Sebastian Giebel, Joanna Dziaczkowska, Tomasz Czerw, Jerzy Wojnar, Malgorzata Krawczyk-Kulis, Izabela Nowak, Aleksandra Holowiecka, Antonio Segatti, Slawomira Kyrcz-Krzemien, Piotr Kusnierczyk, Jerzy Holowiecki

Blood (2009) 114 (22): 3543.

https://doi.org/10.1182/blood.V114.22.3543.3543

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency: a Single Centre Experience.

Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, Tomasz Czerw, Monika Zielinska, Grazyna Bober

Blood (2009) 114 (22): 4362.

https://doi.org/10.1182/blood.V114.22.4362.4362

Published: 2009

Journal Articles

Status of Minimal Residual Disease Determines Outcome of Autologous HSCT in Adults with High-Risk Acute Lymphoblastic Leukemia.

Sebastian Giebel, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Nicola Goekbuget, Dieter Hoelzer, Michael Doubek, Jiri Mayer, Beata Piatkowska-Jakubas, Aleksander Skotnicki, Herve Dombret, Josep-Maria Ribera, Pier Paolo Piccaluga, Tomasz Czerw, Maria Sadus-Wojciechowska, Slawomira Kyrcz-Krzemien, Jerzy Holowiecki

Blood (2009) 114 (22): 2321.

https://doi.org/10.1182/blood.V114.22.2321.2321

Published: 2009

Journal Articles

Addition of Cladribine to the Standard Daunorubicine - Cytarabine (DA 3+7) Remission Induction Protocol (DAC) Contrary to Adjunct of Fludarabine (DAF) Improves the Overall Survival in Untreated Adults with Acute Myeloid Leukemia Aged up to 60 Y: A Multicenter, Randomized, Phase III PALG AML 1/2004 DAF/DAC/DA Study in 673 Patients

Blood (2008) 112 (11): 133.

https://doi.org/10.1182/blood.V112.11.133.133

Published: 2008

Journal Articles

The Impact of NOD2/CARD15, TLR and IL23R Polymorphisms on the Incidence of Infectious Complications in Allo-HSCT Recipients.

Alexandra Maria Holowiecka-Goral, Sebastian Giebel, Jerzy Wojnar, Elzbieta Pietruszka, Agnieszka Karolczyk, Anna Soja, Tomasz Czerw, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Wlodzimierz Mendrek, Beata Stella-Holowiecka, Slawomira Kyrcz-Krzemien

Blood (2008) 112 (11): 2201.

https://doi.org/10.1182/blood.V112.11.2201.2201

Published: 2008

Journal Articles

Killer Immunoglobulin-Like Receptor and NOD2/CARD15 Polymorphisms Independently Influence Survival after Allogeneic Hematopoietic Stem Cell Transplanation.

Sebastian Giebel, Aleksandra Holowecka-Goral, Izabela Nowak, Tomasz Czerw, Jerzy Wojnar, Malgorzata Krawczyk-Kulis, Joanna Dziaczkowska, Miroslaw Markiewicz, Iwona Wylezol, Elzbieta Pietruszka, Piotr Kusnierczyk, Jerzy Holowiecki

Blood (2007) 110 (11): 2167.

https://doi.org/10.1182/blood.V110.11.2167.2167

Published: 2007

Journal Articles

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

Jerzy Holowiecki Prof, Tomasz Czerw, MD, Jerzy Wojnar, MD, PhD, Malgorzata Krawczyk-Kulis, MD, PhD, Sebastian Grosicki, MD, Beata Stella-Holowiecka, MD, PhD, Slawomira Kyrcz-Krzemien Prof, Maria Sadus-Wojciechowska, MD, Sebastian Giebel, MD, Lucja Kachel, MD, Krzysztof Wozniczka, MD, Aleksandra Holowiecka-Goral, MD

Blood (2007) 110 (11): 2875.

https://doi.org/10.1182/blood.V110.11.2875.2875

Published: 2007

Journal Articles

The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.

Aleksandra Holowiecka-Goral, MD, Sebastian Giebel, MD, Izabela Nowak, PhD, Tomasz Czerw, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Elzbieta Pietruszka, PhD, Miroslaw Markiewicz, MD, Piotr Kusnierczyk, MD, Iwona Wylezol, MD, Jerzy Holowiecki Prof

Blood (2007) 110 (11): 2968.

https://doi.org/10.1182/blood.V110.11.2968.2968

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The Importance of the Number of Transplanted Cells with Dipeptidyl Peptidase-4 Expression on the Hematopoietic Recovery and Lymphocyte Reconstitution in Patients with Multiple Myeloma after Autologous Hematopoietic Stem-Cell Transplantation

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

CD26+ (dipeptidyl peptidase IV positive) Cells In Harvest Material For Multiple Myeloma Autotransplantation

Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma – a Retrospective Analysis

Efficacy and Safety of Conditioning Treatment Using Bendamustine in Autologous Hematopoietic Cell Transplantation in Heavily Pretreated Patient with Lymphoma

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

ATG Use Is Associated with Frequent Occurrence of Positive Blood Cultures in Patients in the Early Phase After Hematopoietic Stem Cell Transplantation

The Outcome of Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukaemia: A Single Centre 10-Year-Experience

The Outcome of Autologous Stem Cell Transplantation and the Risk of Relapse in Myeloma and Lymphoma Patients Mobilized Using Plerixafor Compared to Standard Mobilization Regimen

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

High-Dose Immunosuppressive Therapy (Cyclophosphamide and Campath-1H) Followed by Autologous Hematopoietic Stem Cell Transplantation In the Treatment of Systemic Sclerosis.

Sequential Acquisition of Inhibitory NK Cell Receptors After Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Steroids and Other Transplantation-Related Factors.

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency: a Single Centre Experience.

Status of Minimal Residual Disease Determines Outcome of Autologous HSCT in Adults with High-Risk Acute Lymphoblastic Leukemia.

The Impact of NOD2/CARD15, TLR and IL23R Polymorphisms on the Incidence of Infectious Complications in Allo-HSCT Recipients.

Killer Immunoglobulin-Like Receptor and NOD2/CARD15 Polymorphisms Independently Influence Survival after Allogeneic Hematopoietic Stem Cell Transplanation.

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only